Monitor for actual commercial agreements or revenue guidance before treating this as a catalyst. The company's diversified business (medical, defense) adds uncertainty to the quantum narrative.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 31 $0.9000entry
- T+1 · 4mo ago +12.22%α +10.80% · $1.01
- T+5 · 3mo ago +16.67%α +13.16% · $1.05
- T+20 · 3mo ago −7.33%α −10.32% · $0.8340
- T+60 · 22d ago +43.33%α +40.88% · $1.29
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
QTREX announced that its proprietary printed coaxial quantum interconnect platform exceeded RF performance requirements set by strategic partners, including continuous broadband transmission from 10 MHz to 20 GHz, >68 dB crosstalk isolation, and picosecond-level timing precision. This technical validation removes a key scalability barrier for quantum computing infrastructure but is a pre-commercial milestone with no revenue or contract disclosed, and the company's historical stock performance on prior announcements has been poor.
Key Facts
- Proprietary coaxial quantum interconnect platform exceeded strategic partner RF performance requirements across all measured parameters.
- Continuous broadband transmission from 10 MHz to 20 GHz with no resonance or discontinuity.
- Crosstalk suppression maintained at minimum 68 dB below source signal across entire band.
- Channel-to-channel skew above 1 GHz of only 4.4 picoseconds; group delay spread of 2 picoseconds.
- Insertion-loss variation of 0.33 dB, impedance variation <0.3 ohms, forward/reverse transmission agreement within 0.06 dB.
- No revenue, contract, or financial figures disclosed in the press release.
- Company also has medical technology portfolio (respiratory support, blood monitoring) and AME applications for defense/aerospace.
Financial Impact
No financial figures disclosed; pre-commercial technical milestone with no revenue or contract value stated.
Risk Factors
- No revenue or contract disclosed, technical validation does not guarantee commercial adoption.
- Company has multiple business lines (medical, defense, quantum), quantum segment may not be the primary value driver.
- Forward-looking statements are aspirational; no timeline for commercialization provided.
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3336830 |
Track record
28 reports on QTEX
6 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +115.29% at T+5 after the Oct 1, 2026 report. 7 of 8 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Bearish 5/10 Entry $1.19 Now $1.15 +3.35% settles Nov 23
- Nov 16, 2026today Press Release Neutral 4/10 Entry $1.22 Now $1.15 −5.74% settles Nov 23
- Nov 12, 20264d ago Press Release Neutral 3/10 Entry $1.19 Now $1.15 −3.36% settles Nov 19
- Oct 19, 202628d ago 6-K Neutral 3/10 Entry $1.40 to $1.29 Now $1.15 −17.86% ▼ −7.86% −7.71% vs SPY
- Oct 19, 202628d ago Press Release Neutral 3/10 Entry $1.40 to $1.29 Now $1.15 −17.86% ▼ −8.21% −8.07% vs SPY
- Oct 1, 20266w ago 6-K Bullish 6/10 Entry $0.7850 to $1.69 Now $1.15 +46.50% ▲ +115.29% +113.99% vs SPY
- Oct 1, 20266w ago Press Release Bullish 6/10 Entry $0.7850 to $1.69 Now $1.15 +46.50% ▲ +115.29% +113.99% vs SPY
- Sep 24, 20267w ago 6-K Mixed 6/10 Entry $0.7760 to $1.10 Now $1.15 +48.20% ▲ +41.75% +41.97% vs SPY
- Sep 24, 20267w ago Press Release Mixed 5/10 Entry $0.7603 to $0.7846 Now $1.15 +51.26% ▲ +3.20% +3.61% vs SPY
- Sep 2, 202610w ago 6-K Bullish 7/10 Entry $0.8160 to $0.8184 Now $1.15 +40.93% ▲ +0.29% +1.25% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers